Humans of AI3SD: Dr Al Dossetter

Pauli, Michelle and Dossetter, Alexander G. , Frey, Jeremy G., Kanza, Samantha and Niranjan, Mahesan (eds.) (2022) Humans of AI3SD: Dr Al Dossetter (Humans-of-AI3SD, 21) University of Southampton 7pp. (doi:10.5258/SOTON/AI3SD0225).

Record type: Monograph (Project Report)

Abstract

This forms part of our Humans of AI3SD Series.

In this Humans of AI4SD interview he discusses whether the rules of medicinal chemistry actually work, achieving `sensible AI', and the importance of being able to learn quickly.

Text

Humans_of_AI3SD_Interview-21_AD (1) - Version of Record

Available under License Creative Commons Attribution.

Download (260kB)

More information

Published date: 2022

Additional Information: Al Dossetter is the co-founder of MedChemica, which is centred around the technology of Matched Molecular Pair Analysis (MMPA) as a method of accelerating medicinal chemistry. MedChemica now licenses a suite of arti�cial intelligence software and databases for organisations to extract and share knowledge from their own data. The software and methodologies have been used by chemists in many pharmaceutical companies, universities and bio-techs to accelerate drug discovery programmes. Previous to MedChemica Al gained his PhD from Nottingham University and after post-doctoral research at Harvard University joined AstraZeneca.

Keywords: AI3SD, Interview

Learn more about Vision, Learning and Control research Learn more about Institute for Life Sciences research